{"id":6938,"date":"2013-03-22T14:26:06","date_gmt":"2013-03-22T14:26:06","guid":{"rendered":"https:\/\/www.nicox.com\/nicox-resultats-financiers-2012-et-actualite-de-la-societe\/"},"modified":"2013-03-22T14:26:06","modified_gmt":"2013-03-22T14:26:06","slug":"nicox-resultats-financiers-2012-et-actualite-de-la-societe","status":"publish","type":"post","link":"https:\/\/www.nicox.com\/fr\/nicox-resultats-financiers-2012-et-actualite-de-la-societe\/","title":{"rendered":"Nicox : R\u00e9sultats Financiers 2012 et Actualit\u00e9 de la Soci\u00e9t\u00e9"},"content":{"rendered":"

Sophia Antipolis, France.<\/p>\n

Nicox S.A.<\/strong> (NYSE Euronext Paris: COX) annonce aujourd\u2019hui ses r\u00e9sultats financiers pour l\u2019ann\u00e9e 2012 et donne une vue d\u2019ensemble de ses activit\u00e9s.<\/p>\n

\n

Michele Garufi, Pr\u00e9sident Directeur G\u00e9n\u00e9ral de Nicox<\/strong>, a declar\u00e9: \u00ab En 2012, nous avons progress\u00e9 dans notre strat\u00e9gie de transformation de Nicox en une soci\u00e9t\u00e9 internationale sp\u00e9cialis\u00e9e en ophtalmologie. Ces progr\u00e8s ont \u00e9t\u00e9 rendus possibles gr\u00e2ce notre plateforme de recherche brevet\u00e9e, leader au niveau mondial, et gr\u00e2ce aux partenariats internationaux conclus avec des soci\u00e9t\u00e9s de premier plan.<\/em> \u00bb<\/p>\n

\u00ab Le potentiel de notre plateforme de recherche de compos\u00e9s donneurs d\u2019oxyde nitrique dans le domaine ophtalmique a \u00e9t\u00e9 confirm\u00e9 par les r\u00e9sultats positifs obtenus dans une vaste \u00e9tude de phase 2b conduite par notre partenaire Bausch + Lomb pour le latanoprost\u00e8ne bunod, notre candidat m\u00e9dicament d\u00e9couvert au sein de nos Laboratoires de Recherche \u00e0 Milan. Ces r\u00e9sultats ont conduit Bausch + Lomb \u00e0 initier un programme d\u2019\u00e9tudes cliniques de phase 3 qui a d\u00e9marr\u00e9 en janvier cette ann\u00e9e. \u00bb<\/i><\/p>\n

\u00ab L\u2019ann\u00e9e 2012 a \u00e9galement \u00e9t\u00e9 marqu\u00e9e, en octobre, par un premier lancement commercial concernant AdenoPlus\u2122 men\u00e9 par notre nouvelle \u00e9quipe aux Etats-Unis. Ce dispositif m\u00e9dical de diagnostic rapide et utilisable directement en cabinet pour faciliter le diagnostic diff\u00e9rentiel de la conjonctivite aigu\u00eb a \u00e9t\u00e9 pris en licence aupr\u00e8s de RPS\u00ae en juin 2012. \u00bb<\/i><\/p>\n

\u00ab L\u2019organisation de la Soci\u00e9t\u00e9 a \u00e9t\u00e9 structur\u00e9e de mani\u00e8re \u00e0 pr\u00e9parer son expansion pr\u00e9vue en tant que soci\u00e9t\u00e9 ophtalmique internationale int\u00e9gr\u00e9e disposant d\u2019une pr\u00e9sence commerciale aux Etats-Unis et dans les cinq principaux march\u00e9s europ\u00e9ens. Nous attendons une poursuite soutenue de nos progr\u00e8s en 2013 avec la mise en place de nouveaux accords de licence, de co-d\u00e9veloppement et de commercialisation pour des produits th\u00e9rapeutiques et des dispositifs m\u00e9dicaux de diagnostic innovants. \u00bb<\/i><\/p>\n<\/blockquote>\n

 <\/p>\n

\n

Eric Castaldi, Directeur Financier de Nicox, a comment\u00e9 : <\/strong>\u00ab En 2012, Nicox a enregistr\u00e9 une augmentation significative de son chiffre d\u2019affaires suite au paiement d\u2019\u00e9tape de $10 millions de Bausch + Lomb. A mesure que nous investissons dans la construction d\u2019une soci\u00e9t\u00e9 sp\u00e9cialis\u00e9e en ophtalmologie, nos d\u00e9penses op\u00e9rationnelles \u00e9voluent de la R&D vers des frais commerciaux et de corporate development. Au 31 d\u00e9cembre 2012, la Soci\u00e9t\u00e9 disposait d\u2019une tr\u00e9sorerie et d\u2019\u00e9quivalents de tr\u00e9sorerie de plus de \u20ac77 millions nous donnant la flexibilit\u00e9 pour continuer \u00e0 investir dans des opportunit\u00e9s strat\u00e9giques permettant le d\u00e9veloppement commercial de notre soci\u00e9t\u00e9. \u00bb<\/i><\/p>\n<\/blockquote>\n","protected":false},"excerpt":{"rendered":"

R\u00e9sultats financiers annuels 2012 et vue d\u2019ensemble des activit\u00e9s<\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[32,16],"tags":[],"class_list":["post-6938","post","type-post","status-publish","format-standard","hentry","category-actualites","category-actualites-et-media"],"acf":[],"yoast_head":"\nNicox : R\u00e9sultats Financiers 2012 et Actualit\u00e9 de la Soci\u00e9t\u00e9 - Nicox<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.nicox.com\/fr\/nicox-resultats-financiers-2012-et-actualite-de-la-societe\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nicox : R\u00e9sultats Financiers 2012 et Actualit\u00e9 de la Soci\u00e9t\u00e9 - Nicox\" \/>\n<meta property=\"og:description\" content=\"R\u00e9sultats financiers annuels 2012 et vue d\u2019ensemble des activit\u00e9s\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.nicox.com\/fr\/nicox-resultats-financiers-2012-et-actualite-de-la-societe\/\" \/>\n<meta property=\"og:site_name\" content=\"Nicox\" \/>\n<meta property=\"article:published_time\" content=\"2013-03-22T14:26:06+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-resultats-financiers-2012-et-actualite-de-la-societe\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-resultats-financiers-2012-et-actualite-de-la-societe\\\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Nicox : R\u00e9sultats Financiers 2012 et Actualit\u00e9 de la Soci\u00e9t\u00e9\",\"datePublished\":\"2013-03-22T14:26:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-resultats-financiers-2012-et-actualite-de-la-societe\\\/\"},\"wordCount\":444,\"publisher\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\"},\"articleSection\":[\"Actualit\u00e9s\",\"Actualit\u00e9s et M\u00e9dia\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-resultats-financiers-2012-et-actualite-de-la-societe\\\/\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-resultats-financiers-2012-et-actualite-de-la-societe\\\/\",\"name\":\"Nicox : R\u00e9sultats Financiers 2012 et Actualit\u00e9 de la Soci\u00e9t\u00e9 - Nicox\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#website\"},\"datePublished\":\"2013-03-22T14:26:06+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.nicox.com\\\/fr\\\/nicox-resultats-financiers-2012-et-actualite-de-la-societe\\\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/\",\"name\":\"Nicox\",\"description\":\"Visible Science\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#organization\",\"name\":\"Nicox\",\"url\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Nicox\"},\"image\":{\"@id\":\"https:\\\/\\\/www.nicox.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nicox : R\u00e9sultats Financiers 2012 et Actualit\u00e9 de la Soci\u00e9t\u00e9 - Nicox","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.nicox.com\/fr\/nicox-resultats-financiers-2012-et-actualite-de-la-societe\/","og_locale":"fr_FR","og_type":"article","og_title":"Nicox : R\u00e9sultats Financiers 2012 et Actualit\u00e9 de la Soci\u00e9t\u00e9 - Nicox","og_description":"R\u00e9sultats financiers annuels 2012 et vue d\u2019ensemble des activit\u00e9s","og_url":"https:\/\/www.nicox.com\/fr\/nicox-resultats-financiers-2012-et-actualite-de-la-societe\/","og_site_name":"Nicox","article_published_time":"2013-03-22T14:26:06+00:00","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.nicox.com\/fr\/nicox-resultats-financiers-2012-et-actualite-de-la-societe\/#article","isPartOf":{"@id":"https:\/\/www.nicox.com\/fr\/nicox-resultats-financiers-2012-et-actualite-de-la-societe\/"},"author":{"name":"","@id":""},"headline":"Nicox : R\u00e9sultats Financiers 2012 et Actualit\u00e9 de la Soci\u00e9t\u00e9","datePublished":"2013-03-22T14:26:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.nicox.com\/fr\/nicox-resultats-financiers-2012-et-actualite-de-la-societe\/"},"wordCount":444,"publisher":{"@id":"https:\/\/www.nicox.com\/fr\/#organization"},"articleSection":["Actualit\u00e9s","Actualit\u00e9s et M\u00e9dia"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.nicox.com\/fr\/nicox-resultats-financiers-2012-et-actualite-de-la-societe\/","url":"https:\/\/www.nicox.com\/fr\/nicox-resultats-financiers-2012-et-actualite-de-la-societe\/","name":"Nicox : R\u00e9sultats Financiers 2012 et Actualit\u00e9 de la Soci\u00e9t\u00e9 - Nicox","isPartOf":{"@id":"https:\/\/www.nicox.com\/fr\/#website"},"datePublished":"2013-03-22T14:26:06+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.nicox.com\/fr\/nicox-resultats-financiers-2012-et-actualite-de-la-societe\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.nicox.com\/fr\/#website","url":"https:\/\/www.nicox.com\/fr\/","name":"Nicox","description":"Visible Science","publisher":{"@id":"https:\/\/www.nicox.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.nicox.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.nicox.com\/fr\/#organization","name":"Nicox","url":"https:\/\/www.nicox.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.nicox.com\/fr\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Nicox"},"image":{"@id":"https:\/\/www.nicox.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":""}]}},"_links":{"self":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/posts\/6938","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/comments?post=6938"}],"version-history":[{"count":0,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/posts\/6938\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/media?parent=6938"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/categories?post=6938"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nicox.com\/fr\/wp-json\/wp\/v2\/tags?post=6938"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}